Beacon Biosignals
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Software · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
80 Revere St Apt 10, Boston, Massachuset...Website
beacon.bioRevenue
$21 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
3
3
2
2
About Beacon Biosignals
Beacon Biosignals, is a neurotechnology company applying artificial intelligence to EEG (electroencephalography) to unlock precision medicine for any condition affecting the brain. Beacon Biosignals was founded in 2019 and is based in Boston, Massachusetts.Explore more
Beacon Biosignals Org Chart
Get the full picture
Sign in to uncover key details.
LE
Director, Product, Wearable Devices
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Beacon Biosignals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Beacon Biosignals had a recent Job posting/layoffs
Check if Beacon Biosignals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Beacon Biosignals
Check out if Beacon Biosignals is spiking on competitors!
Funding: Get notified immidiatlly once Beacon Biosignals has new funding data
Beacon Biosignals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Beacon Biosignals recently announced quarterly report
Product Launch: Get notified when Beacon Biosignals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Beacon Biosignals
Compare insights from companies similar to Beacon Biosignals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Beacon Biosignals is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Beacon Biosignals is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Beacon Biosignals.
Beacon Biosignals financials insights
Gather financial insights about Beacon Biosignals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$27M
2025
Series B
$86M
2026
Series B
$97M
Beacon Biosignals Tech Stack
A closer look at the technologies used by Beacon Biosignals
Most Recent Scoops
Open Position
Open Position
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Person-Based
Person-Based
Beacon Biosignals News & Media
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today announced an extension to its Series B financing, bringing the funding round to $97 million and the company’s cumulative funding to over $132 million. The upsized round includes new investors JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next.Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
Beacon Biosignals partners with Harmony Biosciences to quantitatively measure excessive daytime sleepiness in phase 3 clinical trial.Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery
BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leading neurotechnology company powering AI-driven neurodiagnostics and precision medicines for the brain, today announced a multi-year expansion of its strategic collaboration with Takeda, which began in 2024. This extension leverages the Beacon Platform to accelerate data-driven development of sleep biomarkers and patterns, and supports new diagnostic pathways that close longstanding care gaps for people with narcolepsy. Under theBeacon Biosignals: $86 Million Series B Raised To Advance AI-Driven Neurodiagnostics ...
Beacon Biosignals has raised an oversubscribed $86 million Series B to accelerate the clinical adoption of AI-powered biomarkers for neurological and psychiatric disease, expand its precision medicine data platform, and scale its neurodiagnostic infrastructure. The financing was backed by Innoviva, Google Ventures (GV), Nexus NeuroTech Ventures, S32, Catalio Capital Management, and Takeda, with continued participation from General Catalyst, Logos Capital, Casdin Capital, and Indicator Ventures.
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Beacon Biosignals
Sign Up For FreeTo access detailed company insights
Beacon Biosignals, is a neurotechnology company applying artificial intelligence to EEG (electroencephalography) to unlock precision medicine for any condition affecting the brain. Beacon Biosignals was founded in 2019 and is based in Boston, Massachusetts.... Read More
